Tissue engineering designs for the future: New logics, old molecules

Tissue Engineering

Volumn 6, Issue 1, 2000, Pages 1-8

  Caplan, Arnold I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ANIMAL TISSUE; BIOENGINEERING; BONE DEFECT; DEVELOPMENTAL BIOLOGY; EMBRYONAL TISSUE; EXPERIMENTATION; MESENCHYME; MOLECULAR BIOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; SPONGE; STEM CELL; TISSUE; TISSUE DIFFERENTIATION; TISSUE REGENERATION;

ANIMALS; BIOMEDICAL ENGINEERING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYALURONIC ACID; RABBITS; REGENERATION; TISSUE TRANSPLANTATION;

EID: 0034003435     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/107632700320838     Document Type: Note

References (42)

1. Caplan, A.I., and Bruder, S.P. Cell and molecular engineering of bone regeneration. In: Lanza, R.P., Chick, W.L., and Langer, R., eds. Principles of Tissue Engineering. Springer, NY: R.G. Landes Co., 1996, pp. 599-618.
2. Caplan, A.I., Fink, D.J., Bruder, S.P., Young, R.G., and Butler, D.L. The regeneration of skeletal tissues using mesenchymal stem cells. In: Patrick, Jr., C.W., Mikos, A.G., and McIntire, L.V., eds. Frontiers in Tissue Engineering. New York: Elsevier Science, 1998, pp. 471-480.
3. Linsenmayer, T.F., Toole, B.P., and Trelstad, R.L. Temporal and spatial transitions in collagen types during embryonic limb development. Dev. Biol. 35, 232-239, 1973.
4. Hinchlifee, J.R., and Johnson, D.R. The Development of the Vertebrate Limb. New York: Oxford University Press, 1980.
5. Caplan, A.I. The mesengenic process. Clin. Plast. Surg. 21, 429-435, 1994.
6. Caplan, A.I. The extracellular matrix is instructive. Bioessays 5, 129-143, 1986.
7. Toolle, B.P. Hyaluronan in morphogenesis. J. Intern. Med. 242, 35-40, 1997.
8. Maor, G., von der Mark, K., Heinegard D., and Silberman, M. Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 125, 1239-1245, 1989.
9. Caplan, A.I., and Boyan B.D. Endochondral bone formation: the lineage cascade. In: Hall, B., ed. Bone. Volume 8. Boca Raton, FL: CRC Press, Chapter 1, 1994, pp. 1-46.
10. Caplan, A.I., Fiszman, M.Y., and Eppenberger, H.M. Molecular and cell isoforms during development. Science 221, 921-927, 1983.
11. Stockdale, F.E. Mechanisms of formation of muscle fiber types. Cell Struct. Funct. 22, 37-43, 1997.
12. Aydelotte, M.B., and Kuettner, K.E. Heterogenesity of articular chondrocytes and cartilage matrix. In: Woessner, J.F., and Howell, D.S., eds. Joint Cartilage Degradation. New York: Marcel Dekker, 1993, pp. 37-65.
13. Bandman, E.R., Matsuda, R., and Strohmen, R. Developmental appearance of myosin heavy and light chain isoforms in vivo and in vitro in chicken skeletal muscle. Dev. Biol. 95, 508-519, 1982.
14. Crow, M.T., and Stockdale, F.E. Myosin isoforms and the cellular basis of skeletal muscle development. Exp. Biol. Med. 9, 165-174, 1984.
15. Urist, M.R. The search for and discovery of bone morphogenetic protein (BMP). In: Urist, M.R., O'Connor, B.T., and Burwell, R.G., eds. Bone Grafts, Derivatives and Substitutes. London: Butterworth Heinemann, 1998, pp. 315-362.
16. Wang, E.A., Israel, D.I., Kelly, S., and Luxenberg, D.P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and #T3 cells. Growth Factors 9, 567-571, 1993.
17. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921, 1996.
18. Kim, W.S., Vacanti, J.P., Cima, L., et al. Cartilage engineered in predetermined shapes employing cell transplantation on synthetic biodegradable polymers. Plast. Reconstr. Surg. 94, 233-240, 1994.
19. Khouri, R.K., Koudsi, B., and Reddi, A.H. Tissue transformation into bone in vivo. JAMA 266, 1953-1955, 1991.
20. Caplan, A.I., Elyaderani, M., Mochizuki, Y., Wakitani, S., and Goldberg, V.M. The principles of cartilage repair/regeneration. Clin. Orthop. Rel. Res. 342, 254-269, 1997.
21. Brittberg, M., Lindahl, A., Milsson, A., Ohlsson, C., Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocytes transplantation. N. Engl. J. Med. 331, 889-895, 1994.
22. Johnstone, B., Hering, T.M., Goldberg, V.M., Yoo, J.U., and Caplan, A.I. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238, 265-272, 1998.
23. Yoo, J.U., Barthel, T.S., Nishimura, K., et al. The chondrogenic potential of human bone marrow-derived mesenchymal progenitor cells. J. Bone Joint Surg. 80, 1745-1757, 1998.
24. Yoshikawa, T., Ohgushi, H., and Tamai, S. Immediate bone-forming capability of prefabricated osteogenic hydroxyapatite. J. Biomed. Mater. Res. 32, 481-492, 1996.
25. Campbell, C.J. Homotransplantation of a half or whole joint. Clin. Orthop. 87, 146-155, 1972.
26. Poitout, D., and Novakovitch, G. Use of allografts in oncology and traumatology. Int. Orthop. 11, 699-707, 1987.
27. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell Biochem. 64, 295-312, 1997.
28. Ohgushi, H., Goldberg, V.M., and Caplan, A.I. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J. Orthop. Res. 7, 568-578, 1989.
29. Dennis, J.E., Haynesworth, S.E., Young, R.G., and Caplan, A.I. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant. 1, 23-32, 1992.
30. Wakitani, S., Goto, T., Pineda, S.J., et al. Mesenchymal cell-based repair of large full-thickness defects of articular cartilage and underlying bone. J. Bone Joint Surg. 76, 579-592, 1994.
31. Campoccia, D., Doherty, P., Radice, M., Brun, P., Abatangelo, G., and Williams, D.F. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19, 2101-2127, 1998.
32. Rastrelli, A., Beccaro, M., Biviano, F., Calderini, G., and Pastorello, A. Hyaluronic acid esters, a new class of semi-synthetic biopolimers: chemical and physico-chemical properties. Clin. Implant Mater. 9, 199-205, 1990.
33. Kujawa, M.J., and Caplan, A.I. Hyaluronic acid bonded to cell culture surfaces stimulates chondrogenesis in stage 24 limb mesenchyme cell cultures. Dev. Biol. 114, 504-518, 1986.
34. Deed, R., Rooney, P., Kumar, P., et al. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelia cells. Inhibition by nonangiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 71, 25, 1997.
35. Solchaga, L.A., Dennis, J.E., Goldberg, V.M., and Caplan, A.I. Hyaluronic acid-based polymers as cell carriers for tissue engineered repair of bone and cartilage. J. Orthop. Res, 17, 205-213, 1999.
36. Solchaga, L., Yoo, J., Lundberg, M., Hubregtse, B., and Caplan, A.I. Hyaluronic acid-based polymers in the treatment of osteochondral defects. Trans. Orthop. Res. Soc. 24, 56, 1999.
37. Solchaga, L., Yoo, J.U., Lundberg, M., Goldberg, V.M., and Caplan, A.I. Augmentation of the repair of osteochondral defects by autologous bone marrow in a hyaluronic acid-based delivery vehicle. Trans. Orthop. Res. Soc. 24, 801, 1999.
38. Mochizuki, Y., Elyaderani, M., Young, R.G., Goldberg, V.M., and Caplan, A.I. Mesenchymal stem cell implantation into a pretreated large full-thickness articular cartilage defect. Trans. Orthop. Res. Soc. 20, 367, 1995.
39. Hascall, V.C., and Heinegård, D. Aggregation of cartilage proteoglycans. J. Biol. Chem. 249, 4242-4249, 1974.
40. Kimura, J.H., Hardingham, T.E., Hascall, V.C., and Solursh, M. Biosynthesis of proteoglycans and their assembly into aggregates in cultures of chondrocytes from the swarm rat chondrosarcoma. J. Biol. Chem. 25, 7134-7143, 1980.
41. LaCrox, P. The organization of bones. London: J.E. Churchill, Ltd., 1951.
42. Shiang, R., Thompson, L.M., Zhu, Y.Z., et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism - achondroplasia. Cell 78, 335-342, 1994.